SCHEMBL3465602

SCHEMBL3465602

CCOc1ccccc1-c1ccc(F)c(F)c1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTPRC P08575 1/20 0.59
NR3C1 P04150 1/20 0.51
DHFR P00374 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.47
DHODH Q02127 2/20 0.47
ALOX5AP P20292 6/20 0.46
FEN1 P39748 6/20 0.46
FGFR1 P11362 1/20 0.45
FGFR2 P21802 1/20 0.45
PDE10A Q9Y233 1/20 0.44
HTR2C P28335 2/20 0.43
HTR2A P28223 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
GCGR P47871 1/20 0.42
MAPK14 Q16539 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3571448 0.82 PTPRC (0.57) PTPRCNR3C1DHFRL3MBTL1PDE10A
SCHEMBL5025945 0.81 ALOX5AP (0.56) PTPRCDHFRL3MBTL1ALOX5APFEN1
SCHEMBL18134264 0.80 FGFR2 (0.45) PTPRCL3MBTL1FGFR1FGFR2
SCHEMBL27637475 0.80 L3MBTL1 (0.51) PTPRCNR3C1DHFRL3MBTL1ALOX5AP
SCHEMBL27324839 0.77 PTPRC (0.58) PTPRCDHFRL3MBTL1PDE10ATDP1
SCHEMBL27707593 0.76 PTPRC (0.51) PTPRCNR3C1DHFRL3MBTL1DHODH
SCHEMBL203121 0.76 ADRB2 (0.61) PTPRCL3MBTL1TDP1
SCHEMBL198911 0.75 ALDH1A1 (0.60) PTPRCL3MBTL1CYP1A2CYP2D6CYP2C19
SCHEMBL12999516 0.75 SYK (0.59) PTPRCDHFRL3MBTL1PDE10ATDP1
SCHEMBL21469977 0.75 PTPRC (0.50) PTPRCNR3C1DHODHALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240678-A1 LEUKOTRIENE B4 INHIBITORS DOMINIQUE ROMYR 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240678-A1 LEUKOTRIENE B4 INHIBITORS LTB4R2, LTB4R, LTC4S PTPRC 3180/4885NR3C1 777/4885DHFR 744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.